Faruqi and Faruqui, LLP Logo
Share this page

Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.)


In the Namenda case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Actavis’ memantine hydrochloride, sold under the brand name Namenda and Namenda XR.  The complaint alleges that Actavis engaged in an illegal product hop to move the market from Namenda to Namenda XR in order to thwart competition from generic Namenda.

Contact Counsel

Peter Kohn
Joseph T. Lukens
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 10/14/2015

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.